TY - JOUR T1 - The fecal microbiome in diverticulitis and asymptomatic diverticulosis: A case-control study in the US JF - medRxiv DO - 10.1101/19001404 SP - 19001404 AU - Meredith A. J. Hullar AU - Richard S. Sandstrom AU - John A. Stamatoyannopoulos AU - Johanna W. Lampe AU - Lisa L. Strate Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/07/12/19001404.abstract N2 - Objective The intestinal microbiota are hypothesized to play a role in the pathogenesis of diverticulitis. We compared fecal microbial communities in individuals with diverticulitis to those with uncomplicated diverticulosis.Methods We used 16S ribosomal RNA gene sequencing to assess and compare the microbiota composition of fecal samples from 10 patients presenting with acute diverticulitis (cases) and 10 controls with asymptomatic diverticulosis matched on age and sex.Results We found differences in the distribution of relative abundances of bacterial phyla and genera in diverticulitis cases versus diverticulosis controls. At the phyla level, Verrucomicrobia was more abundant on average in diverticulitis cases at the time of diagnosis than in diverticulosis controls (p=0.07). Univariate analysis identified a significant increase in the genera Coriobacteria (p=0.050), Anaerotruncus (0.046), Subdoliganulum (p=0.034), Marvinabryantia (p=0.006), and Akkermansia (p=0.04), and a decrease in Barnesiella (p=0.035) and Coprococcus (p=0.035) in diverticulitis cases at the time of diagnosis compared to diverticulosis controls. However, after correction for multiple comparisons, these differences were no longer significant. Partial least squares discriminant analysis on all microbial genera showed partial separation of diverticulitis cases at diagnosis and diverticulosis controls. The microbial alpha diversity was higher in diverticulitis cases at time of diagnosis vs controls but this was not significant (Shannon diversity index 7.4±0.6 vs 6.8±0.7, p=0.08).Conclusions Individuals with diverticulitis differ from those with asymptomatic diverticulosis based on components of the fecal microbiome.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot a clinical trialFunding StatementThis work was supported by grants R01 DK084157 from the National Institutes of Health. None of the authors or their institutions at any time received payment or services from a third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesSequences have been deposited in the Sequence Read Archive of NCBI under accession number SUB2127005 ER -